"Dosing the first patient in our Phase 1/2 trial of NEO-811 in renal cell carcinoma marks a pivotal inflection point for Neomorph, representing the first clinical evaluation of an asset from our ...
Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone ...
Treatment-naive patients with metastatic renal cell carcinoma receive encapsulated fecal microbiota transplants with ...
In this video, Elizabeth Plimack, MD, MS, FASCO, Deputy Director at Fox Chase Cancer Center, discusses current treatments for ...
Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring This retrospective cohort study used integrated claims and clinical data from a commercial health ...
In this video, Elizabeth Plimack, MD, MS, FASCO, Deputy Director at Fox Chase Cancer Center, discusses early detection of renal cell carcinoma.
In this phase 2a study, researchers aimed to determine whether donor fecal microbiota transplantation improved survival in mRCC patients receiving immunotherapy.
An Italian study published in Nature Medicine provides compelling evidence that fecal microbiota transplantation (FMT) can ...
During a live event, Sumanta K. Pal and other oncologists discuss the safety and efficacy of belzutifan for advanced renal ...
In a recent study, mean sensitivity was 85.5% and specificity 87% for detection of clear-cell renal cell carcinoma. (HealthDay News) — ⁸⁹Zr-labeled monoclonal antibody ([⁸⁹Zr]Zr-girentuximab) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results